Yanamandra and colleagues reported a significant increase of 4- to 8-fold of the mean and median values of alpha-synuclein antibody levels in PD patients throughout the progression of their disease, compared to a very narrow distribution in healthy controls [26]. The gene discussed is SNCA; the disease is Parkinson disease.